ArticleRadiation oncology (London, England)2021

Cytoreductive radiotherapy combined with abiraterone in metastatic castration-resistance prostate cancer: a single center experience.

Yang Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.